These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34414545)

  • 1. A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper.
    Seo MK; Strong M
    Pharmacoeconomics; 2021 Dec; 39(12):1373-1381. PubMed ID: 34414545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review.
    Seo MK; Cairns J
    BMC Cancer; 2021 Sep; 21(1):980. PubMed ID: 34470603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer.
    Seo MK; Cairns J
    PLoS One; 2018; 13(9):e0204496. PubMed ID: 30256829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist.
    Doble B; Tan M; Harris A; Lorgelly P
    Expert Rev Mol Diagn; 2015 Feb; 15(2):235-54. PubMed ID: 25142227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of test accuracy in economic evaluations of companion diagnostics.
    San Miguel L; Hulstaert F
    J Comp Eff Res; 2015 Nov; 4(6):569-77. PubMed ID: 26529499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.
    Heather EM; Payne K; Harrison M; Symmons DP
    Pharmacoeconomics; 2014 Feb; 32(2):109-34. PubMed ID: 24338344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost Implications of Value-Based Pricing for Companion Diagnostic Tests in Precision Medicine.
    Zaric GS
    Pharmacoeconomics; 2016 Jul; 34(7):635-44. PubMed ID: 26899833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic challenges facing pharmacogenomics.
    Cohen J; Wilson A; Manzolillo K
    Pharmacogenomics J; 2013 Aug; 13(4):378-88. PubMed ID: 22231566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing Economic Models for Assessing the Cost-Effectiveness of Multiple Diagnostic Tests: Methods and Applications.
    Xie X; Tiggelaar S; Guo J; Wang M; Vandersluis S; Ungar WJ
    Med Decis Making; 2022 Oct; 42(7):861-871. PubMed ID: 35373634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensions of Health Economic Evaluations in R for Microsoft Excel Users: A Tutorial for Incorporating Heterogeneity and Conducting Value of Information Analyses.
    Naylor NR; Williams J; Green N; Lamrock F; Briggs A
    Pharmacoeconomics; 2023 Jan; 41(1):21-32. PubMed ID: 36437359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of cost-effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia.
    Gaultney JG; Sanhueza E; Janssen JJ; Redekop WK; Uyl-de Groot CA
    Pharmacogenomics; 2011 Mar; 12(3):411-21. PubMed ID: 21449679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early cost-effectiveness modeling for better decisions in public research investment of personalized medicine technologies.
    Ling DI; Lynd LD; Harrison M; Anis AH; Bansback N
    J Comp Eff Res; 2019 Jan; 8(1):7-19. PubMed ID: 30525982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paying for personalized care: cancer biomarkers and comparative effectiveness.
    Thariani R; Veenstra DL; Carlson JJ; Garrison LP; Ramsey S
    Mol Oncol; 2012 Apr; 6(2):260-6. PubMed ID: 22429896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers.
    Atherly AJ; Camidge DR
    Br J Cancer; 2012 Mar; 106(6):1100-6. PubMed ID: 22374459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ENVIRONMENTAL SCAN ON PHARMACEUTICALS REQUIRING COMPANION DIAGNOSTICS.
    Cowling T; Boucher M
    Int J Technol Assess Health Care; 2016 Jan; 32(5):327-336. PubMed ID: 27955717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
    Tazawa Y
    Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
    Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J
    Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group.
    Chan KKW; Cheung MC; Regier DA; Hay A; Louie AV; Cheung WY; Tarride JE; Udayakumar S; Mittmann N
    Curr Oncol; 2021 Sep; 28(5):3649-3658. PubMed ID: 34590616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.